May 6, 2021 -- Bio-Techne reported strong growth in revenues for its third quarter (end-March 31), thanks largely to sales in its protein analysis business.
For the third quarter, Bio-Techne posted revenue of $243.6 million, up 22% compared to last year, with foreign currency exchange having a favorable effect of 3%.
For the first nine months of fiscal year 2021, the company reported revenue of $672 million, up 17% compared to last year.
Additionally, the company reported net sales of its protein sciences segment, which provides an array of platforms useful in various areas of protein analysis, were $185.6 million, a record increase of 28% from $145.5 million for the third quarter of fiscal 2020, according to a release.
Copyright © 2021 scienceboard.net